Molecular Testing for Acute Respiratory Tract Infections: Clinical and Diagnostic Recommendations From the IDSA's Diagnostics Committee.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
17 12 2020
Historique:
received: 09 04 2020
accepted: 30 04 2020
pubmed: 6 5 2020
medline: 26 3 2021
entrez: 6 5 2020
Statut: ppublish

Résumé

The clinical signs and symptoms of acute respiratory tract infections (RTIs) are not pathogen specific. Highly sensitive and specific nucleic acid amplification tests have become the diagnostic reference standard for viruses, and translation of bacterial assays from basic research to routine clinical practice represents an exciting advance in respiratory medicine. Most recently, molecular diagnostics have played an essential role in the global health response to the novel coronavirus pandemic. How best to use newer molecular tests for RTI in combination with clinical judgment and traditional methods can be bewildering given the plethora of available assays and rapidly evolving technologies. Here, we summarize the current state of the art with respect to the diagnosis of viral and bacterial RTIs, provide a practical framework for diagnostic decision making using selected patient-centered vignettes, and make recommendations for future studies to advance the field.

Identifiants

pubmed: 32369578
pii: 5830781
doi: 10.1093/cid/ciaa508
pmc: PMC7454374
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2744-2751

Subventions

Organisme : CSRD VA
ID : IK2 CX001981
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

Published by Oxford University Press for the Infectious Diseases Society of America 2020.

Auteurs

Kimberly E Hanson (KE)

Division of Infectious Diseases, Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Section of Clinical Microbiology, Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, Utah, USA.

Marwan M Azar (MM)

Department of Medicine, Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, Connecticut, USA.

Ritu Banerjee (R)

Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Andrew Chou (A)

Michael E. DeBakey VA Medical Center, Baylor College of Medicine, Houston, Texas, USA.

Robert C Colgrove (RC)

Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA.

Christine C Ginocchio (CC)

Global Medical Affairs, bioMérieux/BioFire Diagnostics, Salt Lake City, Utah, USA.
Department of Pathology and Laboratory Medicine, Hofstra North Shore-Long Island Jewish School of Medicine, Hempstead, New York, USA.

Mary K Hayden (MK)

Division of Infectious Diseases, Department of Medicine, Rush University Medical Center, Chicago, Illinois, USA.
Division of Laboratory Medicine, Department of Pathology, Rush University Medical Center, Chicago, Illinois, USA.

Mark Holodiny (M)

VA Palo Alto Health Care System, Palo Alto, California, USA.
Stanford University, Palo Alto, California, USA.

Seema Jain (S)

Disease Investigations Section, Infectious Diseases Branch, California Department of Public Health, Richmond, California, USA.

Sophia Koo (S)

Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Jaclyn Levy (J)

Infectious Diseases Society of America, Arlington, Virginia, USA.

Tristan T Timbrook (TT)

Division of Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah USA.
Department of Pharmacy, University of Utah Health, Salt Lake City, Utah, USA.

Angela M Caliendo (AM)

Division of Infectious Diseases, Department of Medicine, Brown University Warren Alpert School of Medicine, Providence, Rhode Island, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH